Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical and intravenous tranexamic acid in cardiac surgery
NL-OMON38995Phase 4Active, not recruiting
- Sponsor
- Amphia Ziekenhuis
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in postoperative hemorrhage (3 arms), sponsored by Amphia Ziekenhuis. Primary endpoint: 12-hour postoperative blood loss. Started Nov 2013; status: active, not recruiting.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NL-OMON38995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38995.